GI tract

Clostridium difficile infection (CDI)

Clostridium difficile infection (CDI)

By Dr. Natasha Press on April 29, 2013

In the past few years, a hypervirulent strain of C. difficile, called NAP-1, has caused hospital outbreaks that have been unusually severe and recurrent.

The whole cell cholera and travellers’ diarrhea vaccine – Looking for evidence in the prevention of travellers’ diarrhea

By Dr. Susan Hollenberg on July 10, 2012

The approval of the oral whole cell cholera and traveller’s diarrhea vaccine in Canada promised a novel approach to the prevention of TD.

Proton pump inhibitors and Clostridium difficile infection

By Dr. Ted Steiner on July 4, 2011

Based on recent literature, my current practice is to carefully consider whether PPIs or H2 blockers are truly indicated in inpatients, and to stop them if they are not.

New therapies and new end points in the treatment of Crohn’s Disease

By Dr. Brian Bressler on March 28, 2011

Effectively treating the inflammation in patients with Crohn’s disease has now allowed us to treat not just the symptoms associated with Crohn’s disease, but the disease itself.

Probiotic therapy has changed my approach to treating patients with irritable bowel syndrome

By Dr. Brian Bressler on July 26, 2010

Recently there has been clinical evidence for using probiotics for various medical conditions, including treatment of acute gastroenteritis, prevention of antibiotic-associated diarrhea and IBS.

Visit UBC CPD at ubccpd.ca

UBC CPD website

View all CPD learning activities: virtual, in-person and hybrid conferences, workshops, webinars, online modules, customized community courses, simulation hands-on courses, coaching, mentoring, personalized learning, recordings, and more.

Visit UBC CPD ↗

This field is for validation purposes and should be left unchanged.